BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9092958)

  • 1. Preliminary observations on topiramate in pediatric epilepsies.
    Glauser TA
    Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate.
    Glauser TA
    Semin Pediatr Neurol; 1997 Mar; 4(1):34-42. PubMed ID: 9097365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.
    Glauser TA; Levisohn PM; Ritter F; Sachdeo RC
    Epilepsia; 2000; 41(S1):86-90. PubMed ID: 10768308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary open-label experience with topiramate in primary generalized seizures.
    Biton V
    Epilepsia; 1997; 38 Suppl 1():S42-4. PubMed ID: 9092959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
    Ben-Menachem E
    Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.
    Faught E
    Epilepsia; 1997; 38 Suppl 1():S24-7. PubMed ID: 9092954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate: a review of its use in childhood epilepsy.
    Ormrod D; McClellan K
    Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonfocal generalized tonic-clonic seizures: response during long-term topiramate treatment. Topiramate YTC/YTCE Study Group.
    Montouris GD; Biton V; Rosenfeld WE
    Epilepsia; 2000; 41(S1):77-81. PubMed ID: 10768306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group.
    Ritter F; Glauser TA; Elterman RD; Wyllie E
    Epilepsia; 2000; 41(S1):82-5. PubMed ID: 10768307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
    Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
    Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
    Abou-Khalil B
    Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment.
    Rosenfeld WE; Sachdeo RC; Faught RE; Privitera M
    Epilepsia; 1997; 38 Suppl 1():S34-6. PubMed ID: 9092957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate use in pediatric patients.
    Glauser TA
    Can J Neurol Sci; 1998 Aug; 25(3):S8-12. PubMed ID: 9706734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy.
    Tassinari CA; Michelucci R; Chauvel P; Chodkiewicz J; Shorvon S; Henriksen O; Dam M; Reife R; Pledger G; Karim R
    Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate. Clinical profile in epilepsy.
    Sachdeo RC
    Clin Pharmacokinet; 1998 May; 34(5):335-46. PubMed ID: 9592618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
    Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of topiramate in children with Lennox-Gastaut syndrome.
    Guerreiro MM; Manreza ML; Scotoni AE; Silva EA; Guerreiro CA; Souza EA; Ferreira VB; Reed UC; Diament A; Trefiglio R; Chiu HC; Bacaltchuk J
    Arq Neuropsiquiatr; 1999 Jun; 57(2A):167-75. PubMed ID: 10412513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.